
Monetize Telegram Mini App with Telega.io
Connect your app, set CPM, and watch your revenue grow!
Start monetizing
7.3

Advertising on the Telegram channel «Cardiology Updates»
Health & Medicine
Language:
English
0
0
Share
Add to favorite
Buy advertising in this channel
Placement Format:
keyboard_arrow_down
- 1/24
- 2/48
- 3/72
- Native
- 7 days
- Forwards
1 hour in the top / 24 hours in the feed
Quantity
%keyboard_arrow_down
- 1
- 2
- 3
- 4
- 5
- 8
- 10
- 15
Advertising publication cost
local_activity
$3.60$3.60local_mall
0.0%
Remaining at this price:0
Recent Channel Posts
Letter by Santini and Pola Regarding Article, “Rivaroxaban for 18 Months versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)”
https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.124.073416?af=R
https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.124.073416?af=R
1140
14:22
09.09.2025
Home-based care improves blood pressure control
https://www.nature.com/articles/s41569-025-01214-2
Nature Reviews Cardiology, Published online: 09 September 2025; doi:10.1038/s41569-025-01214-2 (https://www.nature.com/articles/s41569-025-01214-2)A home-based model of hypertension care can lower blood pressure in patients with hypertension compared with standard care in the clinic, according to the IMPACT-BP trial, which was performed in a rural setting in South Africa and presented at the ESC Congress 2025.
https://www.nature.com/articles/s41569-025-01214-2
Nature Reviews Cardiology, Published online: 09 September 2025; doi:10.1038/s41569-025-01214-2 (https://www.nature.com/articles/s41569-025-01214-2)A home-based model of hypertension care can lower blood pressure in patients with hypertension compared with standard care in the clinic, according to the IMPACT-BP trial, which was performed in a rural setting in South Africa and presented at the ESC Congress 2025.
1130
22:12
09.09.2025
Role of Helicobacter pylori screening after myocardial infarction
https://www.nature.com/articles/s41569-025-01215-1
Nature Reviews Cardiology, Published online: 09 September 2025; doi:10.1038/s41569-025-01215-1 (https://www.nature.com/articles/s41569-025-01215-1)Routine screening for Helicobacter pylori infection during hospitalization for myocardial infarction does not reduce the risk of upper gastrointestinal bleeding, according to findings from the HELP-MI SWEDEHEART trial, although secondary and subgroup analyses suggest potential clinically meaningful benefits.
https://www.nature.com/articles/s41569-025-01215-1
Nature Reviews Cardiology, Published online: 09 September 2025; doi:10.1038/s41569-025-01215-1 (https://www.nature.com/articles/s41569-025-01215-1)Routine screening for Helicobacter pylori infection during hospitalization for myocardial infarction does not reduce the risk of upper gastrointestinal bleeding, according to findings from the HELP-MI SWEDEHEART trial, although secondary and subgroup analyses suggest potential clinically meaningful benefits.
1250
22:13
09.09.2025
Baxdrostat beneficial in uncontrolled or resistant hypertension
https://www.nature.com/articles/s41569-025-01216-0
Nature Reviews Cardiology, Published online: 10 September 2025; doi:10.1038/s41569-025-01216-0 (https://www.nature.com/articles/s41569-025-01216-0)In patients with uncontrolled or resistant hypertension, the addition of the aldosterone synthase inhibitor baxdrostat to background antihypertensive therapy reduces seated in-office systolic blood pressure after 12 weeks of treatment, according to findings from the BaxHTN trial presented at the ESC Congress 2025.
https://www.nature.com/articles/s41569-025-01216-0
Nature Reviews Cardiology, Published online: 10 September 2025; doi:10.1038/s41569-025-01216-0 (https://www.nature.com/articles/s41569-025-01216-0)In patients with uncontrolled or resistant hypertension, the addition of the aldosterone synthase inhibitor baxdrostat to background antihypertensive therapy reduces seated in-office systolic blood pressure after 12 weeks of treatment, according to findings from the BaxHTN trial presented at the ESC Congress 2025.
1190
17:19
10.09.2025
Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial
https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.125.075080?af=R
https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.125.075080?af=R
1240
10:56
11.09.2025
Benefit of digitoxin therapy for HFrEF
https://www.nature.com/articles/s41569-025-01217-z
Nature Reviews Cardiology, Published online: 11 September 2025; doi:10.1038/s41569-025-01217-z (https://www.nature.com/articles/s41569-025-01217-z)In the DIGIT-HF trial, treatment with digitoxin in addition to guideline-directed medical therapy reduced the risk of hospitalization for worsening heart failure or all-cause death compared with placebo in patients with heart failure with reduced ejection fraction.
https://www.nature.com/articles/s41569-025-01217-z
Nature Reviews Cardiology, Published online: 11 September 2025; doi:10.1038/s41569-025-01217-z (https://www.nature.com/articles/s41569-025-01217-z)In the DIGIT-HF trial, treatment with digitoxin in addition to guideline-directed medical therapy reduced the risk of hospitalization for worsening heart failure or all-cause death compared with placebo in patients with heart failure with reduced ejection fraction.
1210
16:37
11.09.2025
Arrhythmia-induced cardiomyopathy: focus on atrial fibrillation
https://www.nature.com/articles/s41569-025-01195-2
Nature Reviews Cardiology, Published online: 15 September 2025; doi:10.1038/s41569-025-01195-2 (https://www.nature.com/articles/s41569-025-01195-2)Arrhythmia-induced cardiomyopathy (AIC) refers to heart failure caused or exacerbated by arrhythmias, which resolves completely after restoration of sinus rhythm. In this Review, Fabritz and colleagues focus on atrial fibrillation as the cause of AIC, describing its pathophysiology, epidemiology and clinical presentation, and the various approaches to the diagnostic–therapeutic strategy of rhythm restoration.
https://www.nature.com/articles/s41569-025-01195-2
Nature Reviews Cardiology, Published online: 15 September 2025; doi:10.1038/s41569-025-01195-2 (https://www.nature.com/articles/s41569-025-01195-2)Arrhythmia-induced cardiomyopathy (AIC) refers to heart failure caused or exacerbated by arrhythmias, which resolves completely after restoration of sinus rhythm. In this Review, Fabritz and colleagues focus on atrial fibrillation as the cause of AIC, describing its pathophysiology, epidemiology and clinical presentation, and the various approaches to the diagnostic–therapeutic strategy of rhythm restoration.
348
19:37
15.09.2025
Intimate Partner Violence as a Risk Factor for CVD Deserves Its “Me Too” Movement
https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.125.075752?af=R
https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.125.075752?af=R
1800
10:07
03.09.2025
Cardiac myosin inhibitors for the treatment of obstructive and non-obstructive HCM
https://www.nature.com/articles/s41569-025-01218-y
Nature Reviews Cardiology, Published online: 12 September 2025; doi:10.1038/s41569-025-01218-y (https://www.nature.com/articles/s41569-025-01218-y)Two late-breaking clinical trials presented at the ESC Congress 2025 have explored the efficacy of cardiac myosin inhibitors for the treatment of hypertrophic cardiomyopathy.
https://www.nature.com/articles/s41569-025-01218-y
Nature Reviews Cardiology, Published online: 12 September 2025; doi:10.1038/s41569-025-01218-y (https://www.nature.com/articles/s41569-025-01218-y)Two late-breaking clinical trials presented at the ESC Congress 2025 have explored the efficacy of cardiac myosin inhibitors for the treatment of hypertrophic cardiomyopathy.
1020
18:09
12.09.2025
The prevention of adult cardiovascular disease must begin in childhood: evidence and imperative
https://www.nature.com/articles/s41569-025-01209-z
Nature Reviews Cardiology, Published online: 12 September 2025; doi:10.1038/s41569-025-01209-z (https://www.nature.com/articles/s41569-025-01209-z)In this Review, Khoury and colleagues examine the growing body of evidence demonstrating the benefits of screening for cardiovascular risk factors, including dyslipidaemia and high blood pressure, starting in childhood to reduce the lifetime burden of cardiovascular disease.
https://www.nature.com/articles/s41569-025-01209-z
Nature Reviews Cardiology, Published online: 12 September 2025; doi:10.1038/s41569-025-01209-z (https://www.nature.com/articles/s41569-025-01209-z)In this Review, Khoury and colleagues examine the growing body of evidence demonstrating the benefits of screening for cardiovascular risk factors, including dyslipidaemia and high blood pressure, starting in childhood to reduce the lifetime burden of cardiovascular disease.
1110
18:10
12.09.2025
close
Reviews channel
No reviews
New items
Channel statistics
Rating
7.3
Rating reviews
0.0
Сhannel Rating
0
Subscribers:
14.2K
APV
lock_outline
ER
--%
Posts per day:
0.0
CPM
lock_outlinekeyboard_double_arrow_left
shopping_cart
Channels:
0
Subscribers:
0
Views:
lock_outline
Total:
$0.00
Add to Cart
Clear the cart
Are you sure you want to clear the cart?
You will be able to add channels from the catalog to the cart again.
You will be able to add channels from the catalog to the cart again.
Clear my cart
Cancel
Комментарий